
Saudavel Pharmaceuticals Private Limited
About Saudavel Pharmaceuticals Private Limited
Data last updated:
Saudavel Pharmaceuticals Private Limited is a private limited company based in Margao, Goa, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U51909GA2017PTC013268. Its GSTIN is 30AAYCS8888H1ZF (Goa).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Somnath Gokuldas Shet Shirodkar and Maynard Marius Gomes.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop. No. G – 1 Staircase Desiderio Appartments Varde Valaulikar Rd, Margao, Goa, India – 403601.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Cr, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹1.1 Lakh (net margin -1%) and EBITDA of -₹1.08 Lakh (EBITDA margin -1%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Saudavel Pharmaceuticals Private Limited's registered office is in Margao, Goa. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop. No. G – 1 Staircase Desiderio Appartments Varde Valaulikar Rd, Margao, Goa, India – 403601
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Saudavel Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Saudavel Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Saudavel Pharmaceuticals Private Limited, buy the company report.
Financials of Saudavel Pharmaceuticals Private Limited
FY 2025 filings availableSaudavel Pharmaceuticals Private Limited reported revenue of ₹1.11 Cr (down 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 32% fall in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1% | ||||
| Net Profit Margin | -1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Saudavel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Saudavel Pharmaceuticals Private Limited
Saudavel Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Somnath Gokuldas Shet Shirodkar | Director | 03 Jul 2017 | 9 Years 4 Months | Current |
| Maynard Marius Gomes | Director | 03 Jul 2017 | 9 Years 4 Months | Current |
| Miguel Francisco Gomes | Director | 03 Jul 2017 | 9 Years 4 Months | Current |
Peer comparison
Saudavel Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cellestus Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | 122.0% | Baddi, Himachal Pradesh, India | |||
| Quantrix Healthcare Private Limited | ₹1.11 Cr (FY 2020) | -34.0% | Indore, Madhya Pradesh, India | |||
| Saudavel Pharmaceuticals Private Limitedthis company | ₹1.11 Cr (FY 2025) | -₹1.1 Lakh | -1% | -32.0% | Margao, Goa, India | |
| Rydan Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2025) | 24.0% | Jaipur, Rajasthan, India | |||
| Sreeha Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2021) | 752.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Saudavel Pharmaceuticals Private Limited, buy the company report.
Auditor
Saudavel Pharmaceuticals Private Limited is audited by VILAS V SHANBHAG & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VILAS V SHANBHAG & CO | FY 2020 | 111462W |
Shareholding
The shareholding of Saudavel Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Saudavel Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Saudavel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saudavel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Saudavel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 30AAYCS8888H1ZF | Goa | Active | 09 Aug 2017 |
To see the full GST registrations and return filing status of Saudavel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Saudavel Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Maynard Marius Gomes was appointed as Director on 03 Jul 2017.
Frequently asked questions
Saudavel Pharmaceuticals is an active private limited company based in Margao, Goa, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 July 2017 (9+ years old) and is registered under CIN U51909GA2017PTC013268.
Saudavel Pharmaceuticals has 3 current directors:
- Somnath Gokuldas Shet Shirodkar - Director
- Maynard Marius Gomes - Director
- Miguel Francisco Gomes - Director
The latest financial statements of Saudavel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Saudavel Pharmaceuticals is 30AAYCS8888H1ZF, registered in Goa.
The CIN (Corporate Identification Number) of Saudavel Pharmaceuticals is U51909GA2017PTC013268. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saudavel Pharmaceuticals was incorporated on 03 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Goa.
The peers of Saudavel Pharmaceuticals by revenue are Cellestus Pharmaceuticals Private Limited, Quantrix Healthcare Private Limited, Rydan Pharmaceuticals Private Limited, Sreeha Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Maynard Marius Gomes was appointed as Director on 03 Jul 2017. Miguel Francisco Gomes was appointed as Director on 03 Jul 2017. Somnath Gokuldas Shet Shirodkar was appointed as Director on 03 Jul 2017.
The registered office of Saudavel Pharmaceuticals is at Shop. No. G – 1 Staircase Desiderio Appartments Varde Valaulikar Rd, Margao, Goa, India – 403601.
Saudavel Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Saudavel Pharmaceuticals is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.

